▶ 調査レポート

バイオバンキングの世界市場:市場規模、シェア、成長、動向、予測

• 英文タイトル:Biobanking Market (Product: Equipment, Consumables, and Software & Services; Biospecimen: Blood Products, Human Tissues, Cell Lines, Nucleic Acids, and Others; Application: Therapeutics, Clinical Diagnostics, Drug Discovery & Development, and Others; Storage: Manual and Automated) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2019 - 2027

Transparency Market Researchが調査・発行した産業分析レポートです。バイオバンキングの世界市場:市場規模、シェア、成長、動向、予測 / Biobanking Market (Product: Equipment, Consumables, and Software & Services; Biospecimen: Blood Products, Human Tissues, Cell Lines, Nucleic Acids, and Others; Application: Therapeutics, Clinical Diagnostics, Drug Discovery & Development, and Others; Storage: Manual and Automated) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2019 - 2027 / TPM-NV176資料のイメージです。• レポートコード:TPM-NV176
• 出版社/出版日:Transparency Market Research / 2019年10月28日
• レポート形態:英文、PDF、238ページ
• 納品方法:Eメール
• 産業分類:医療
• 販売価格(消費税別)
  Single User¥631,655 (USD5,795)▷ お問い合わせ
  Multi User¥958,655 (USD8,795)▷ お問い合わせ
  Global Site License¥1,285,655 (USD11,795)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本資料は、バイオバンキングの世界市場について調べ、バイオバンキングの世界市場規模、市場動向、市場シェア、市場環境、市場予測、製品別(機器、消耗品、およびソフトウェア&サービス)分析、生体試料別(血液製剤、ヒト組織、細胞株、核酸、その他)分析、用途別(治療、臨床診断、創薬および開発、その他)分析、ストレージ別(手動および自動化)分析、関連企業情報などをまとめました。
・バイオバンキングの市場概要
・バイオバンキングの市場動向
・バイオバンキングの世界市場規模・予測
・バイオバンキング市場:製品別(機器、消耗品、およびソフトウェア&サービス)
・バイオバンキング市場:生体試料別(血液製剤、ヒト組織、細胞株、核酸、その他)
・バイオバンキング市場:生体試料別(血液製剤、ヒト組織、細胞株、核酸、その他)
・バイオバンキング市場:ストレージ別(手動および自動化)
・地域別分析(北米、ヨーロッパ、アジア太平洋、中東・アフリカ、南米)
・競争環境・関連企業分析

The collected terabytes of biological data and its associated information are revolutionizing healthcare infrastructure across nations. Likewise, stakeholders in the biobanking market are increasing their focus on personalized medicines to meet the growing demand for the specific diagnosis for rare-case diseases. In 2017, North America topped the list of major countries in the world, and contributed ~17% of its GDP towards healthcare spending. Correspondingly, North America is projected to dominate market revenue throughout the forecast period in the biobanking market.

Healthcare companies are seeking result-oriented outcomes in personalized medicine space though the development of new drugs. This is being made possible with the help of high-quality biospecimens from biobanks. Thus, stakeholders in the biobanking market and healthcare companies are closely related, as the early detection and prevention of diseases is heavily dependent upon the data received by companies on specific biomarkers. Growing awareness about the types of cancer, cardiovascular diseases, and neurological disorders are paving the way for emanant development of a personalized medicine ecosystem.

レポート目次

1. Preface

1.1. Report Scope and Market Segmentation

1.2. Research Highlights

2. Assumptions and Research Methodology

2.1. Assumptions and Acronyms Used

2.2. Research Methodology

3. Executive Summary

3.1. Global Biobanking Market: Market Snapshot

4. Market Overview

4.1. Global Biobanking Market: Product Overview

4.2. Global Biobanking Market: Key Industry Developments

4.3. Market Dynamics

4.3.1. Drivers

4.3.2. Restraints

4.3.3. Opportunities

4.4. Global Biobanking Market Revenue Projections, 2017–2027

4.5. Global Biobanking Market Outlook

5. Market Outlook

5.1. Key Mergers & Acquisitions

5.2. Technological Advancements

5.3. Healthcare Industry Overview

5.4. Regulatory Scenario by Region/globally

5.5. List of Major Biobanks, by Region

5.6. List of Vendors Supporting Automated Biobanking

6. Global Biobanking Market Analysis, by Product

6.1. Key Findings

6.2. Introduction

6.3. Global Biobanking Market Value Share and Attractiveness Analysis, by Product

6.4. Global Biobanking Market Forecast, by Product

6.4.1. Equipment

6.4.1.1. Temperature Control Systems

6.4.1.1.1. Freezers & Refrigerators

6.4.1.1.2. Cryogenic Storage Systems

6.4.1.1.3. Thawing Equipment

6.4.1.1.4. Incubators & Centrifuges

6.4.1.2. Alarms & Monitoring Systems

6.4.1.3. Accessories & Other equipment

6.4.2. Consumables

6.4.2.1. Cryovials & Cryomolds

6.4.2.2. Tubes

6.4.2.3. Others

6.4.3. Software & Services

6.5. Global Biobanking Market Analysis, by Product, 2017–2027

7. Global Biobanking Market Analysis, by Biospecimen Type

7.1. Key Findings

7.2. Introduction

7.3. Global Biobanking Market Value Share and Attractiveness Analysis, by Biospecimen Type

7.4. Global Biobanking Market Forecast, by Biospecimen Type

7.4.1. Blood Products

7.4.2. Human Tissues

7.4.3. Cell Lines

7.4.4. Nucleic Acids

7.4.5. Others

7.5. Global Biobanking Market Analysis, by Biospecimen Type, 2017–2027

8. Global Biobanking Market Analysis, by Application

8.1. Key Findings

8.2. Introduction

8.3. Global Biobanking Market Value Share and Attractiveness Analysis, by Application

8.4. Global Biobanking Market Forecast, by Application

8.4.1. Therapeutics

8.4.2. Clinical Diagnostics

8.4.3. Drug Discovery & Development

8.4.4. Others

8.5. Global Biobanking Market Analysis, by Application, 2017–2027

9. Global Biobanking Market Analysis, by Storage Type

9.1. Key Findings

9.2. Introduction

9.3. Global Biobanking Market Value Share and Attractiveness Analysis, by Storage Type

9.4. Global Biobanking Market Forecast, by Storage Type

9.4.1. Manual

9.4.2. Automated

9.5. Global Biobanking Market Analysis, by Storage Type, 2017–2027

10. Global Biobanking Market Analysis, by Region

10.1. Global Biobanking Market Scenario, by Country

10.2. Global Biobanking Market Value Share and Attractiveness Analysis, by Region

10.3. Global Biobanking Market Forecast, by Region

10.3.1. North America

10.3.2. Europe

10.3.3. Asia Pacific

10.3.4. Latin America

10.3.5. Middle East & Africa

11. North America Biobanking Market Analysis

11.1. Key Findings

11.2. North America Biobanking Market Value Share and Attractiveness Analysis, by Country

11.3. North America Biobanking Market Forecast, by Country

11.3.1. U.S.

11.3.2. Canada

11.4. North America Biobanking Market Value Share and Attractiveness Analysis, by Product

11.5. North America Biobanking Market Forecast, by Product

11.5.1. Equipment

11.5.1.1. Temperature Control Systems

11.5.1.1.1. Freezers & Refrigerators

11.5.1.1.2. Cryogenic Storage Systems

11.5.1.1.3. Thawing Equipment

11.5.1.2. Incubators & Centrifuges

11.5.1.3. Alarms & Monitoring Systems

11.5.1.4. Accessories & Other equipment

11.5.2. Consumables

11.5.2.1. Cryovials & Cryomolds

11.5.2.2. Tubes

11.5.2.3. Others

11.5.3. Software & Services

11.6. North America Biobanking Market Value Share and Attractiveness Analysis, by Biospecimen Type

11.7. North America Biobanking Market Forecast, by Biospecimen Type

11.7.1. Blood Products

11.7.2. Human Tissues

11.7.3. Cell Lines

11.7.4. Nucleic Acids

11.7.5. Others

11.8. North America Biobanking Market Value Share and Attractiveness Analysis, by Application

11.9. North America Biobanking Market Forecast, by Application

11.9.1. Therapeutics

11.9.2. Clinical Diagnostics

11.9.3. Drug Discovery & Development

11.9.4. Others

11.10. North America Biobanking Market Value Share and Attractiveness Analysis, by Storage Type

11.11. North America Biobanking Market Forecast, by Storage Type

11.11.1. Manual

11.11.2. Automated

12. Europe Biobanking Market Analysis

12.1. Key Findings

12.2. Europe Biobanking Market Value Share and Attractiveness Analysis, by Country/Sub-region

12.3. Europe Biobanking Market Forecast, by Country/Sub-region

12.3.1. Germany

12.3.2. U.K.

12.3.3. France

12.3.4. Italy

12.3.5. Spain

12.3.6. Rest of Europe

12.4. Europe Biobanking Market Value Share and Attractiveness Analysis, by Product

12.5. Europe Biobanking Market Forecast, by Product

12.5.1. Equipment

12.5.1.1. Temperature Control Systems

12.5.1.1.1. Freezers & Refrigerators

12.5.1.1.2. Cryogenic Storage Systems

12.5.1.1.3. Thawing Equipment

12.5.1.2. Incubators & Centrifuges

12.5.1.3. Alarms & Monitoring Systems

12.5.1.4. Accessories & Other equipment

12.5.2. Consumables

12.5.2.1. Cryovials & Cryomolds

12.5.2.2. Tubes

12.5.2.3. Others

12.5.3. Software & Services

12.6. Europe Biobanking Market Value Share and Attractiveness Analysis, by Biospecimen Type

12.7. Europe Biobanking Market Forecast, by Biospecimen Type

12.7.1. Blood Products

12.7.2. Human Tissues

12.7.3. Cell Lines

12.7.4. Nucleic Acids

12.7.5. Others

12.8. Europe Biobanking Market Value Share and Attractiveness Analysis, by Application

12.9. Europe Biobanking Market Forecast, by Application

12.9.1. Therapeutics

12.9.2. Clinical Diagnostics

12.9.3. Drug Discovery & Development

12.9.4. Others

12.10. Europe Biobanking Market Value Share and Attractiveness Analysis, by Storage Type

12.11. Europe Biobanking Market Forecast, by Storage Type

12.11.1. Manual

12.11.2. Automated

13. Asia Pacific Biobanking Market Analysis

13.1. Key Findings

13.2. Asia Pacific Biobanking Market Value Share and Attractiveness Analysis, by Country/Sub-region

13.3. Asia Pacific Biobanking Market Forecast, by Country/Sub-region

13.3.1. China

13.3.2. Japan

13.3.3. India

13.3.4. Australia & New Zealand

13.3.5. Rest of Asia Pacific

13.4. Asia Pacific Biobanking Market Value Share and Attractiveness Analysis, by Product

13.5. Asia Pacific Biobanking Market Forecast, by Product

13.5.1. Equipment

13.5.1.1. Temperature Control Systems

13.5.1.1.1. Freezers & Refrigerators

13.5.1.1.2. Cryogenic Storage Systems

13.5.1.1.3. Thawing Equipment

13.5.1.2. Incubators & Centrifuges

13.5.1.3. Alarms & Monitoring Systems

13.5.1.4. Accessories & Other equipment

13.5.2. Consumables

13.5.2.1. Cryovials & Cryomolds

13.5.2.2. Tubes

13.5.2.3. Others

13.5.3. Software & Services

13.6. Asia Pacific Biobanking Market Value Share and Attractiveness Analysis, by Biospecimen Type

13.7. Asia Pacific Biobanking Market Forecast, by Biospecimen Type

13.7.1. Blood Products

13.7.2. Human Tissues

13.7.3. Cell Lines

13.7.4. Nucleic Acids

13.7.5. Others

13.8. Asia Pacific Biobanking Market Value Share and Attractiveness Analysis, by Application

13.9. Asia Pacific Biobanking Market Forecast, by Application

13.9.1. Therapeutics

13.9.2. Clinical Diagnostics

13.9.3. Drug Discovery & Development

13.9.4. Others

13.10. Asia Pacific Biobanking Market Value Share and Attractiveness Analysis, by Storage Type

13.11. Asia Pacific Biobanking Market Forecast, by Storage Type

13.11.1. Manual

13.11.2. Automated

14. Latin America Biobanking Market Analysis

14.1. Key Findings

14.2. Latin America Biobanking Market Value Share and Attractiveness Analysis, by Country/Sub-region

14.3. Latin America Biobanking Market Forecast, by Country/Sub-region

14.3.1. Brazil

14.3.2. Mexico

14.3.3. Rest of Latin America

14.4. Latin America Biobanking Market Value Share and Attractiveness Analysis, by Product

14.5. Latin America Biobanking Market Forecast, by Product

14.5.1. Equipment

14.5.1.1. Temperature Control Systems

14.5.1.1.1. Freezers & Refrigerators

14.5.1.1.2. Cryogenic Storage Systems

14.5.1.1.3. Thawing Equipment

14.5.1.2. Incubators & Centrifuges

14.5.1.3. Alarms & Monitoring Systems

14.5.1.4. Accessories & Other equipment

14.5.2. Consumables

14.5.2.1. Cryovials & Cryomolds

14.5.2.2. Tubes

14.5.2.3. Others

14.5.3. Software & Services

14.6. Latin America Biobanking Market Value Share and Attractiveness Analysis, by Biospecimen Type

14.7. Latin America Biobanking Market Forecast, by Biospecimen Type

14.7.1. Blood Products

14.7.2. Human Tissues

14.7.3. Cell Lines

14.7.4. Nucleic Acids

14.7.5. Others

14.8. Latin America Biobanking Market Value Share and Attractiveness Analysis, by Application

14.9. Latin America Biobanking Market Forecast, by Application

14.9.1. Therapeutics

14.9.2. Clinical Diagnostics

14.9.3. Drug Discovery & Development

14.9.4. Others

14.10. Latin America Biobanking Market Value Share and Attractiveness Analysis, by Storage Type

14.11. Latin America Biobanking Market Forecast, by Storage Type

14.11.1. Manual

14.11.2. Automated

15. Middle East & Africa Biobanking Market Analysis

15.1. Key Findings

15.2. Middle East & Africa Biobanking Market Value Share and Attractiveness Analysis, by Country/Sub-region

15.3. Middle East & Africa Biobanking Market Forecast, by Country/Sub-region

15.3.1. GCC Countries

15.3.2. South Africa

15.3.3. Rest of Middle East & Africa

15.4. Middle East & Africa Biobanking Market Value Share and Attractiveness Analysis, by Product

15.5. Middle East & Africa Biobanking Market Forecast, by Product

15.5.1. Equipment

15.5.1.1. Temperature Control Systems

15.5.1.1.1. Freezers & Refrigerators

15.5.1.1.2. Cryogenic Storage Systems

15.5.1.1.3. Thawing Equipment

15.5.1.2. Incubators & Centrifuges

15.5.1.3. Alarms & Monitoring Systems

15.5.1.4. Accessories & Other equipment

15.5.2. Consumables

15.5.2.1. Cryovials & Cryomolds

15.5.2.2. Tubes

15.5.2.3. Others

15.5.3. Software & Services

15.6. Middle East & Africa Biobanking Market Value Share and Attractiveness Analysis, by Biospecimen Type

15.7. Middle East & Africa Biobanking Market Forecast, by Biospecimen Type

15.7.1. Blood Products

15.7.2. Human Tissues

15.7.3. Cell Lines

15.7.4. Nucleic Acids

15.7.5. Others

15.8. Middle East & Africa Biobanking Market Value Share and Attractiveness Analysis, by Application

15.9. Middle East & Africa Biobanking Market Forecast, by Application

15.9.1. Therapeutics

15.9.2. Clinical Diagnostics

15.9.3. Drug Discovery & Development

15.9.4. Others

15.10. Middle East & Africa Biobanking Market Value Share and Attractiveness Analysis, by Storage Type

15.11. Middle East & Africa Biobanking Market Forecast, by Storage Type

15.11.1. Manual

15.11.2. Automated

16. Competition Landscape

16.1. Company Profiles

16.1.1. Thermo Fisher Scientific, Inc.

16.1.1.1. Company Overview (HQ, Business Segments, Employee Strength)

16.1.1.2. Company Financials

16.1.1.3. Growth Strategies

16.1.1.4. SWOT Analysis

16.1.2. PHC Holdings Corporation (Panasonic Healthcare)

16.1.2.1. Company Overview (HQ, Business Segments, Employee Strength)

16.1.2.2. Growth Strategies

16.1.2.3. SWOT Analysis

16.1.3. Hamilton Company

16.1.3.1. Company Overview (HQ, Business Segments, Employee Strength)

16.1.3.2. Company Financials

16.1.3.3. Growth Strategies

16.1.3.4. SWOT Analysis

16.1.4. Chart Industries, Inc.

16.1.4.1. Company Overview (HQ, Business Segments, Employee Strength)

16.1.4.2. Company Financials

16.1.4.3. Growth Strategies

16.1.4.4. SWOT Analysis

16.1.5. VWR International, LLC. (Avantor, Inc.)

16.1.5.1. Company Overview (HQ, Business Segments, Employee Strength)

16.1.5.2. Growth Strategies

16.1.5.3. SWOT Analysis

16.1.6. QIAGEN N.V.

16.1.6.1. Company Overview (HQ, Business Segments, Employee Strength)

16.1.6.2. Company Financials

16.1.6.3. Growth Strategies

16.1.6.4. SWOT Analysis

16.1.7. Greiner AG

16.1.7.1. Company Overview (HQ, Business Segments, Employee Strength)

16.1.7.2. Company Financials

16.1.7.3. Growth Strategies

16.1.7.4. SWOT Analysis

16.1.8. Brooks Automation, Inc.

16.1.8.1. Company Overview (HQ, Business Segments, Employee Strength)

16.1.8.2. Company Financials

16.1.8.3. Growth Strategies

16.1.8.4. SWOT Analysis

16.1.9. Merck KGaA

16.1.9.1. Company Overview (HQ, Business Segments, Employee Strength)

16.1.9.2. Company Financials

16.1.9.3. Growth Strategies

16.1.9.4. SWOT Analysis

16.1.10. Tecan Trading AG

16.1.10.1. Company Overview (HQ, Business Segments, Employee Strength)

16.1.10.2. Company Financials

16.1.10.3. Growth Strategies

16.1.10.4. SWOT Analysis